Fundraising FoxBrickell Biotech
Miami, US · Founded 2009 · Delaware corporation
Find your way into Brickell Biotech
Sign up to see every warm intro you have to Brickell Biotech
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Brickell Biotech team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
Brickell Biotech was founded in 2009 by Andrew Sklawer.
AS
Andrew SklawerFounder
GS
Gerard S. Coombs, CPAExecutive
CJ
Charles J. Betlach, Ph.D.Executive
RC
Richard C. Bulman, Jr.Executive
DA
David AnguloExecutive
RL
Reginald L. HardyNamed on SEC filing
Board
CW
Charles W. StiefelBoard director
DT
Dennison T. VeruBoard director
WD
William D. JuBoard director
GB
George B. AbercrombieBoard director
DE
David E. CohenBoard director
Reported raises · per SEC filings
Form D private placements$9.5M disclosed across 2 rounds · 2014–2015
▶$7.3MraisedFeb 2015 · 30 investors · PharmaceuticalsRule 506(b)
▶$7.3MraisedFeb 2015 · 30 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Gerard S. Coombs, CPAExecutive Officer
- Andrew SklawerExecutive Officer
- William D. JuDirector
- Charles J. Betlach, Ph.D.Executive Officer
- George B. AbercrombieDirector
- Charles W. StiefelDirector
- Reginald L. HardyExecutive Officer, Director
- Richard C. Bulman, Jr.Executive Officer
- David AnguloExecutive Officer
- Dennison T. VeruDirector
- Offering amount
- $10M
- Amount sold
- $7.3M
- First sale
- Feb 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$2.2MraisedAug 2014 · 24 investors · PharmaceuticalsRule 506(b)
▶$2.2MraisedAug 2014 · 24 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Charles W. StiefelDirector
- Andrew SklawerExecutive Officer
- David AnguloExecutive Officer
- George B. AbercrombieDirector
- Charles J. Betlach, Ph.D.Executive Officer
- Dennison T. VeruDirector
- Richard C. Bulman, Jr.Executive Officer
- David E. CohenDirector
- Reginald L. HardyExecutive Officer, Director
- Gerard S. Coombs, CPAExecutive Officer
- Offering amount
- $3M
- Amount sold
- $2.2M
- First sale
- Jul 2014
- Incorporated
- Corporation, Delaware, 2009
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who founded Brickell Biotech?
- Brickell Biotech was founded by Andrew Sklawer in 2009.
- How much funding has Brickell Biotech raised?
- Brickell Biotech has disclosed $9.5M raised across 2 rounds.
- Where is Brickell Biotech headquartered?
- Brickell Biotech is headquartered in Miami, US.